Two recent publications add to our knowledge concerning the utility of CYP2D6 genotyping and tamoxifen.
TARGET-1: https://www.ncbi.nlm.nih.gov/pubmed/31821071
Tamoxifen D/C rates by 2D6 genotype: https://www.ncbi.nlm.nih.gov/pubmed/31800347
